Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSMA PET/MR in Gynecological Cancers
NCT03302156Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in gynecologic cancer, sponsored by University of Wisconsin–Madison. Started Nov 2017; status: terminated.
02
Drugs
piflufolastat f 18
03
Conditions
gynecologic cancer
Beyond the preview
Go deeper on NCT03302156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302156.